Why Farfetch Shares Are Trading Lower; Here Are 26 Stocks Moving Premarket

Benzinga·11/18/2022 12:43:04

Listen to the news

Gainers

PaxMedica, Inc. (NASDAQ:PXMD) shares rose 58.1% to $2.45 in pre-market trading. PaxMedica entered into committed equity investment agreement for up to $20 million with Lincoln Park Capital.
Secoo Holding Limited (NASDAQ:SECO) shares rose 29.6% to $0.35 in pre-market trading after dropping 7% on Thursday.
IVERIC bio, Inc. (NASDAQ:ISEE) rose 20.9% to $20.84 in pre-market trading. Iveric Bio said that the FDA has granted breakthrough therapy designation for Avacincaptad Pegol for geographic atrophy.
StoneCo Ltd. (NASDAQ:STNE) rose 20% to $11.84 in pre-market trading after the company reported Q3 results.
Ross Stores, Inc. (NASDAQ:ROST) rose 16.6% to $114.20 in pre-market trading after the company reported better-than-expected Q3 results and issued strong earnings guidance.
Quhuo Limited (NASDAQ:QH) rose 15.6% to $1.92 in pre-market trading. Quhuo recently reported better-than-expected H1 results.
Scopus BioPharma Inc. (NASDAQ:SCPS) shares jumped 11.3% to $0.2710 in pre-market trading after dropping 5% on Thursday.
Golden Sun Education Group Limited (NASDAQ:GSUN) rose 9.5% to $2.53 in pre-market trading after dropping 46% on Thursday.
Provention Bio, Inc. (NASDAQ:PRVB) rose 9.1% to $8.99 in pre-market trading. Provention said on Thursday the U.S. Food and Drug Administration has given its nod for the use of TZIELD (teplizumab-mzwb) in those aged eight years and older — the first treatment targeted at delaying the onset of insulin-dependent type 1 diabetes.
Palo Alto Networks, Inc. (NASDAQ:PANW) rose 8.6% to $170.00 in pre-market trading after the company reported better-than-expected results for its second quarter and issued strong FY23 earnings guidance. The company also announced plans to acquire Cider Security for approximately $195 million.
Biora Therapeutics, Inc. (NASDAQ:BIOR) rose 7.4% to $0.2470 in pre-market trading after dropping 8% on Thursday. Biora Therapeutics recently posted a Q3 loss of $0.08 per share.
The Gap, Inc. (NYSE:GPS) rose 7.2% to $13.63 in pre-market trading after the company reported better-than-expected Q3 sales results.
AppHarvest, Inc. (NASDAQ:APPH) rose 7.1% to $1.36 in pre-market trading. AppHarvest recently reported worse-than-expected Q3 sales results.
Virax Biolabs Group Limited (NASDAQ:VRAX) rose 5.7% to $1.49 in pre-market trading. Virax Biolabs recently named Richard Pallin as Vice President of In Vitro Diagnostic Sales.
Applied Materials, Inc. (NASDAQ:AMAT) rose 3.8% to $108.37 in pre-market trading following upbeat quarterly results.

Don’t forget to check out our premarket coverage here .

Losers

Scilex Holding Company (NASDAQ:SCLX) shares fell 28% to $6.72 in pre-market trading after gaining over 6% on Thursday.
G1 Therapeutics, Inc. (NASDAQ:GTHX) fell 24.4% to $6.46 in pre-market trading after the company reported pricing of $50.05 million public offering of 7.7 million shares of common stock at a price of $6.50 per share.
BIMI International Medical, Inc. (NASDAQ:BIMI) shares fell 17.2% to $0.21 in pre-market trading.
Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ:BHAT) shares fell 12.1% to $0.6202 in pre-market trading.
Farfetch Limited (NYSE:FTCH) fell 11.3% to $8.11 in pre-market trading after the company reported worse-than-expected Q3 revenues. Gross merchandise value decreased 4.9% year over year.
Tian Ruixiang Holdings Ltd (NASDAQ:TIRX) fell 10.3% to $2.34 in pre-market trading after dropping 12% on Thursday.
Cuentas Inc. (NASDAQ:CUEN) fell 9.1% to $0.2910 in pre-market trading after jumping 28% on Thursday.
Smart for Life, Inc. (NASDAQ:SMFL) shares fell 9.1% to $0.40 in pre-market trading. Smart for Life recently posted Q3 sales of $5.40 million.
The Very Good Food Company Inc. (NASDAQ:VGFC) fell 8.1% to $0.0715 in pre-market trading after gaining over 6% on Thursday.
Ensysce Biosciences, Inc. (NASDAQ:ENSC) fell 6.7% to $2.37 in pre-market trading after dropping 9% on Thursday.
Zhihu Inc. (NYSE:ZH) fell 6.6% to $1.27 in pre-market trading. Zhihu is expected to report Q3 financial results on November 30, 2022.

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English